Expertise in
4
conditions

Manabu Muto

Kyoto, JP 
Expertise in
4
conditions
Kyoto, JP 

Overview

Manabu Muto practices practicing medicine in Kyoto, Japan.

Mr. Muto is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Esophageal Cancer, Stomach Cancer, Benign Esophageal Stricture, Endoscopy, and Colonoscopy.

He is actively involved in clinical research, co-authoring 343 peer reviewed articles and participating in 1 clinical trial.

Gender

Male

Locations

Kyoto, Japan
Other Locations
Kawahara, 6068507, Japan
Nagoya, 4668550, Japan
Tokyo, Japan
Saitama, 3378570, Japan
Japan
Sagamihara, 2525201, Japan
Chiba, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Randomized, Placebo-Controlled, Double-Blind Phase 3 Study to Evaluate the Efficacy and Safety of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First-Line Treatment in Patients With Unresectable, Locally Advanced Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
A Randomized, Placebo-Controlled, Double-Blind Phase 3 Study to Evaluate the Efficacy and Safety of Tislelizumab (BGB-A317) in Combination With Chemotherapy as First-Line Treatment in Patients With Unresectable, Locally Advanced Recurrent or Metastatic Esophageal Squamous Cell Carcinoma
Enrollment Status: Completed
Publish Date: July 29, 2025
Intervention Type: Drug, Biological
Study Drugs: Cisplatin, Capecitabine, Paclitaxel, Fluorouracil (5-FU), Oxaliplatin, Tislelizumab
Study Phase: Phase 3

343 Total Publications

Correction: An observational study of the effectiveness and safety of nivolumab plus chemotherapy for untreated advanced or recurrent gastric cancer in Japanese real-world settings: the G-KNIGHT study.
Correction: An observational study of the effectiveness and safety of nivolumab plus chemotherapy for untreated advanced or recurrent gastric cancer in Japanese real-world settings: the G-KNIGHT study.
Journal: Gastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association
Published: June 18, 2026

Frequently Asked Questions about Manabu Muto

Is Manabu Muto a top-rated expert for Esophageal Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Manabu Muto is classified as an Distinguished expert for Esophageal Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Manabu Muto participate in research or clinical trials?

Yes. Manabu Muto has published 343 articles and abstracts on conditions like Esophageal Cancer. You can view a list of Manabu Muto's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Muto's expertise for a condition
ConditionClose
    View All 47 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile